Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion type Assertion NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_head.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion description "[One hundred and ninety-five lung tumor samples including 74 (38%) squamous cell carcinomas (SCC), 61 (31%) adenocarcinomas (ADC), 23 (12%) large cell carcinoma (LCC) in non-small cell lung cancer (NSCLC) group and 37 (19%) small cell lung cancer (SCLC) samples were examined for the expression of CD44 using immunohistochemistry method.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_provenance.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion evidence source_evidence_literature NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_provenance.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion SIO_000772 25335738 NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_provenance.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion wasDerivedFrom befree-2016 NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_provenance.
- NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_assertion wasGeneratedBy ECO_0000203 NP1231300.RA7vgThui2Wls2lWso4Q4mdlLlwGn1GQTdq7mYzwE6GqY130_provenance.